Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dietary Management

- PMLiVE

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Best Places to Work logo with winner text

Cuttsy+Cuttsy are named as one of the Best Places to Work

Campaign Magazine have released its 2022 ranking for the best places to work and Cuttsy+Cuttsy have come in right at the top at No.3.

Cuttsy + Cuttsy

- PMLiVE

WHO releases estimates of 14.9 million excess deaths during COVID-19 pandemic

The estimates show the full death toll caused directly or indirectly by the COVID-19 pandemic between 1 January 2020 and 31 December 2021

- PMLiVE

Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients

The collaboration is focused on improving MS patients’ mobility and walking

- PMLiVE

AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US

The drug combination offers biliary tract cancer patients a new treatment option

- PMLiVE

FDA limits use of Janssen’s COVID-19 vaccine

Authorisation of Janssen COVID-19 vaccine restricted among certain people following analysis and evaluation

Applying Vibrotactile Stimulation to Improve Parkinson’s

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how innovative medical devices and software can improve...

Impetus Digital

- PMLiVE

The Michael J Fox Foundation gives Asceneuron second research grant

Parkinson's disease affects an estimated seven to ten million people worldwide

- PMLiVE

Sanofi launches new funding foundation

Foundation S is a philanthropic endowment fund aimed at encouraging healthier lives for future generations

PIF Tick logo - Trusted Information Creator

Promoting trust: Cuttsy+Cuttsy become a PIF Tick accredited agency

Cuttsy+Cuttsy join a host of noteworthy healthcare charities and institutions as one of the first healthcare communications agencies to receive the Patient Information Forum’s seal of approval – the PIF...

Cuttsy + Cuttsy

- PMLiVE

BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients

There are no approved treatment options available for acute agitation related to dementia

- PMLiVE

EC approves Novartis’ Kymriah for advanced blood cancer

Kymriah is the first CAR-T cell therapy of its kind approved in the EU for follicular lymphoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links